Robert Schmouder, Berkeley Heights US
Robert Schmouder, Berkeley Heights, NJ US
Patent application number | Description | Published |
---|---|---|
20100160259 | DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST - S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage | 06-24-2010 |
20110152380 | Paediatric Compositions For Treating Multiple Sclerosis - The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C | 06-23-2011 |
20110257133 | DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST - S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage. | 10-20-2011 |
20120264719 | DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR - S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile. | 10-18-2012 |
20130230489 | Paediatric Compositions For Treating Multiple Sclerosis - The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C | 09-05-2013 |
20140066657 | DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST - S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage | 03-06-2014 |
20140148415 | DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST - S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage. | 05-29-2014 |
20140187516 | DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR - S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile. | 07-03-2014 |